The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2024

Filed:

Mar. 03, 2020
Applicant:

Genzyme Corporation, Cambridge, MA (US);

Inventors:

Marco A. Passini, Shrewsbury, MA (US);

James Dodge, Worcester, MA (US);

Assignee:

Genzyme Corporation, Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07K 14/47 (2006.01); C12N 15/86 (2006.01); C12N 15/864 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0075 (2013.01); A61K 48/00 (2013.01); C07K 14/47 (2013.01); C12N 15/86 (2013.01); C12N 15/8645 (2013.01); C12N 2750/14041 (2013.01); C12N 2750/14143 (2013.01); C12N 2799/025 (2013.01);
Abstract

The disclosure pertains to methods and compositions for treating disorders affecting the central nervous system (CNS). These disorders include neurometabolic disorders such as lysosomal storage diseases that affect the central nervous system, e.g., Niemann-Pick A disease. They also include disorders such as Alzheimer's disease. The disclosed methods involve contacting an axonal ending of a neuron with a composition containing high titer AAV carrying a therapeutic transgene so that the AAV vector is axonally transported in a retrograde fashion and transgene product is expressed distally to the administration site.


Find Patent Forward Citations

Loading…